Agios Pharma (AGIO) Reports Q2 Loss of $1.47/Share

Agios Pharma (NASDAQ: AGIO) reported Q2 EPS of ($1.47), versus ($0.85) reported last year. Revenue for the quarter came in at $6.98 million, versus $13.22 million reported last year.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• AeroVironment (AVAV) Tops Q4 EPS by 36c
• Abivax reports Phase 3 maintenance trial results for obefazimod